CD8A and neoplasm: CD8+ T cells are the main anti-tumor immune cells associated with favorable prognosis in various tumors, and their immune function can be inhibited by regulatory B cells, which further contributes to the functional suppression of anti-tumor immune cells in the IM region (47, 48).